The role of sex and biochemical markers of inflammation in left ventricular remodelling, before and after surgery, in elderly patients with aortic valve stenosis

Hellenic Journal of Cardiology

Volumn 50, Issue 1, 2009, Pages 26-36

  Kastellanos, Stylianos S ^a,d   Toumpoulis, Ioannis K ^b   Aggeli, Constadina ^c   Zezas, Stefanos ^c   Chlapoutakis, Emmanouil ^c   Kastellanos, Stamatis ^b   Stefanadis, Christodoulos I ^c  

^a IASO GENERAL HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Aortic stenosis; Elderly patients; Left ventricular remodelling inflammatory markers

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHEMOATTRACTANT; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPSIN I; TUMOR NECROSIS FACTOR ALPHA;

AGED; AORTA DISEASE; AORTA RECONSTRUCTION; AORTA STENOSIS; AORTA VALVE; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BIOCHEMISTRY; BODY SURFACE; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXAMINATION; FEMALE; FLOW; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PATIENT SELECTION; SEX; SEX ROLE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TUMOR; VELOCITY; VENOUS BLOOD;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 59949086580     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sasayama S, Ross J, Franklin D, et al. Adaptations of the left ventricle to chronic pressure overload. Circ Res. 1976; 38: 172-178.
2. Ross J. Afterload mismatch in aortic and mitral valve disease: implication for surgical therapy. J Am Coll Cardiol. 1985; 5: 811-826.
3. Seiler C, Jenni R. Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors and short-term follow up after aortic valve replacement. Heart. 1996; 76: 250-255.
4. Antoini-Canterin F, Huang G, Cervestato E, et al. Symptomatic aortic stenosis. Does systemic hypertension play an additional role? Hypertension. 2003; 41: 1268-1272.
5. Antigemma G, Silver K, McLaughlin M, et al. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol. 1994; 74: 794-797.
6. Buttric P, Scheuer J. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992; 86: 1336-1338.
7. Rohde L, Zhi G, Aranki S, et al. Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol. 1997; 80: 475-480.
8. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol. 1995; 20: 1068-1079.
9. Carrol J, Carrol E, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992; 86: 1099-1107.
10. Milavetz D, Hayes S, Weson S, et al. Sex-differences in left ventricular geometry in aortic stenosis. Chest. 2000; 117: 1094-1099.
11. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure overload human heart. Structural deterioration and compensatory mechanisms. Circulation. 2003; 107: 984-991.
12. Neumann F, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995; 92: 748-755.
13. Lagrand W, Visser C, Hermens W, et al. C-reactive protein as a cardiovascular risk factor more than an epiphenomenon? Circulation. 1999; 100: 96-102.
14. Wada H, Saito K, Kanda I, et al. Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viral myocarditis in mice: A study using mice lacking TNF-alpha. Circulation. 2001; 103: 743-749.
15. Sheikene Y, Hansson G. Chemokines and atherosclerosis. Ann Med. 2004; 36: 98-118.
16. Shioi T, Matsumori A, Kihara Y, et al. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res. 1997; 81: 664-671.
17. Kastellanos S, Toumpoulis I, Aggeli C, et al. Time course of C-reactive protein, Tumour necrosis factor-alpha, and monocyte chemoattractant protein-1 following the surgical treatment of patients with aortic valve stenosis. Hellenic J Cardiol. 2007; 48: 5-14.
18. Sahn D, Demaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic methods. Circulation. 1978; 58: 1072-1083.
19. Devereux R, Alonso D, Lutas E. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Circulation. 1986; 57: 450-458.
20. Zoghbi W, Farmer K, Soto J, et al. Accurate noninvasive quantification of stenotic aortic valve by Doppler echocardiography. Circulation. 1986; 73: 452-458.
21. Wang M, Yip G, Wang A, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003, 43;820-826.
22. Malhotra A, Buttric P, Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol. 1990; 259: 868-871.
23. Douglas P, Otto C, Mickel M, et al. Gender differences in left ventricular geometry and function in patients undergoing balloon dilation of the aortic valve for isolated aortic stenosis. Br Heart J. 1995; 73: 548-554.
24. Legget M, Kuusisto J, Healy N, et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J. 1996; 131: 94-100.
25. Kostkiewicz M, Tracz W, Olszowska M, et al. Left ventricular geometry and function in patients with aortic stenosis: gender differences. Int J Cardiol. 1999; 71: 57-61.
26. Cohn L. The long-term results of aortic valve replacement. Chest. 1984; 85: 384-396.
27. Pantely G, Morton M, Rahimtoola S. Effects of successful uncomplicated valve replacement on ventricular hypertrophy volume and performance in aortic stenosis and in aortic incompetence. J Thorac Cardiovasc Surg. 1978; 75: 382-391.
28. Jin X, Zhang Z, Gibson D, et al. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg. 1996; 62: 683-690.
29. Xu Y, Pepper J, Brecker S, et al. Early changes in left ventricular function after aortic valve replacement for isolated aortic stenosis. Am J Cardiol. 1994; 74: 442-448.
30. Krayenbuehl HP, Turina M, Hess OM, Rothlin M, Senning A. Pre- and post-operative left ventricular contractile function in patients with aortic valve disease. Br Heart J. 1979; 41: 204-213.
31. Hess O, Ritter M, Schneider J, et al. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation. 1984; 69: 855-865.
32. Villari B, Vassali G, Monrad E, et al. Normalization of diastolic dysfunction in aortic stenosis later after valve replacement. Circulation. 1995; 91: 2353-2358.
33. Krumholz H, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993. 72: 313-1313.
34. Galante A, Pietroinsti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol. 2001; 38: 1078-1082.
35. Gerber I, Stenard R, Hammalt C, et al. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol. 2003; 92: 1129-1132.
36. Psychari SN, Apostolou TS, Iliodromitis EK, Kourakos P, Liakos G, Kremastinos DT. Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic J Cardiol. 2007; 48: 64-71.
37. Aggeli C, Giannopoulos G, Roussakis G, et al. Preejection tissue-Doppler velocity changes during low dose dobutamine stress predict segmental myocardial viability. Hellenic J Cardiol. 2007; 48: 23-29.